Clemastine

Clemastine

SCHEMBL33403

CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Clemastine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 1/20 0.84
CYP3A4 P08684 2/20 1.00
SMN1; SMN2 Q16637 1/20 1.00
MEN1 O00255 1/20 1.00
GMNN O75496 1/20 1.00
LMNA P02545 1/20 1.00
BLM P54132 1/20 1.00
PMP22 Q01453 1/20 1.00
KMT2A Q03164 1/20 1.00
CHRM3 P20309 14/20 0.84
CHRM2 P08172 2/20 0.84
HTR1A P08908 2/20 0.84
ADRA2A P08913 2/20 0.84
CHRM1 P11229 2/20 0.84
DRD1 P21728 2/20 0.84
SLC6A2 P23975 2/20 0.84
SLC6A4 P31645 2/20 0.84
ADRA1A P35348 2/20 0.84
OPRM1 P35372 2/20 0.84
DRD3 P35462 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clemastine SCHEMBL41468 1.00 CYP3A4 (1.00) CYP3A4SMN1; SMN2MEN1GMNNLMNA
Clemastine SCHEMBL18787212 1.00 CYP3A4 (1.00) CYP3A4SMN1; SMN2MEN1GMNNLMNA
Clemastine SCHEMBL27597691 1.00 CYP3A4 (1.00) CYP3A4SMN1; SMN2MEN1GMNNLMNA
Clemastine SCHEMBL28170352 1.00 CYP3A4 (1.00) CYP3A4SMN1; SMN2MEN1GMNNLMNA
Clemastine SCHEMBL4098555 1.00 CYP3A4 (1.00) CYP3A4SMN1; SMN2MEN1GMNNLMNA
Clemastine SCHEMBL15526489 1.00 CYP3A4 (1.00) CYP3A4SMN1; SMN2MEN1GMNNLMNA
Clemastine SCHEMBL3017168 1.00 CYP3A4 (1.00) CYP3A4SMN1; SMN2MEN1GMNNLMNA
Clemastine SCHEMBL4102782 0.94 CYP3A4 (0.89) CYP3A4SMN1; SMN2MEN1GMNNLMNA
Clemastine SCHEMBL23785540 0.92 CHRM3 (1.00) CYP3A4SMN1; SMN2MEN1GMNNLMNA
Clemastine SCHEMBL4087919 0.92 CHRM3 (1.00) CYP3A4SMN1; SMN2MEN1GMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10631 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121740927-B Quartz gene identification method based on scanning electron microscope multi-mode signal fusion Institute of Mineral Resources, Chinese Academy of Geological Sciences (CN) 2026-05-26 CN claimed
CN-121557262-B V-shaped gear box 杭州萧山江南通用机械有限公司 2026-05-19 CN claimed
CN-122040000-A Self-adaptive clamping jaw device for clamping anchor rod and drill rod 安徽理工大学 2026-05-15 CN claimed
CN-122046794-A Double-coefficient compensation method for improving simulation precision of strip-method construction concrete temperature field 湖北工业大学 2026-05-15 CN claimed
CN-116491926-B Infant brain T2 weighted magnetic resonance imaging optimization method 浙江大学 2026-05-12 CN claimed
CN-122023933-A Tomato dynamic growth monitoring method based on robot inspection and digital twin 中国农业大学 2026-05-12 CN claimed
US-20260076872-A1 POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME SIO2 MEDICAL PRODUCTS LLC (US) 2026-03-19 US claimed
CN-121579957-A Rotary machine fault diagnosis method for AHO-VMD-CNN-BiGRU 宜宾职业技术学院 2026-02-27 CN claimed
CN-121187142-B Indoor action planning and action control method and system for humanoid robot and robot 湖南超能机器人技术有限公司 2026-02-27 CN claimed
US-20250242092-A1 SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS SIO2 MEDICAL PRODUCTS INC (US) 2025-07-31 US claimed
EP-0608320-A1 ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS RICHARDSON-VICKS, INC. (US) 1994-08-03 EP claimed
EP-0582380-A1 Dry granulation using a fluidized bed McNEIL-PPC, INC. (US) 1994-02-09 EP claimed
WO-1994002176-A1 PHARMACEUTICAL COMPOSITION FOR TOPICAL USE CONTAINING A CROSSLINKED CATIONIC POLYMER AND AN ALKOXYLATED ETHER THE PROCTER & GAMBLE COMPANY (US) 1994-02-03 WO claimed
US-5273758-A Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms SANDOZ LTD. (CH) 1993-12-28 US claimed
EP-0284913-B1 MAGNETIC-RECORDING MEDIUM FOR TESTING, ESPECIALLY FOR GAUGING MAGNETIC FLYING HEADS BASF Aktiengesellschaft (DE) 1993-05-26 EP claimed
WO-1993007902-A1 ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS RICHARDSON-VICKS, INC. (US) 1993-04-29 WO claimed
EP-0351897-A2 Skin penetration system for salts of amine-functional drugs THE PROCTER & GAMBLE COMPANY (US) 1990-01-24 EP claimed
EP-0316345-A1 LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE LIPOSOME TECHNOLOGY, INC. (US) 1989-05-24 EP claimed
EP-0316345-A4 LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE. LIPOSOME TECHNOLOGY INC (US) 1989-05-16 EP claimed
WO-1988000824-A1 LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE LIPOSOME TECHNOLOGY, INC. (US) 1988-02-11 WO claimed